- Companies
- Tern
Tern Valuation Multiples
Tern is valued at $11M as of November 2026, a 152.4x revenue multiple. In the last fiscal year, Tern revenue was $73K and Tern EBITDA was ($7M).
Tern Overview
About Tern
Tern PLC is an Alternative Investment Market, quoted investment company specialising in investing in private software companies, predominantly in the Internet of Things (IoT) domain.
Founded
2004
HQ
Employees
3
Website
Sectors
Financials (Last FY)
EV
$11M
Valuation Multiples
Start free trialTern Financials
Tern reported last fiscal year revenue of $73K and negative EBITDA of ($7M).
In the same fiscal year, Tern generated ($7M) in EBITDA losses and had net loss of ($7M).
Tern P&L
In the most recent fiscal year, Tern reported revenue of $73K and EBITDA of ($7M).
Tern is unprofitable as of last fiscal year, with EBITDA margin of (9503%) and net margin of (9424%).
Financial data powered by Morningstar, Inc.
Tern Stock Performance
Tern has current market cap of $11M, and enterprise value of $11M.
Market Cap Evolution
Tern's stock price is $0.01.
Tern share price decreased by 5.1% in the last 30 days, and increased by 159.4% in the last year.
Tern has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11M | $11M | -0.0% | -5.1% | -23.0% | 159.4% | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTern Valuation Multiples
Tern trades at 152.4x EV/Revenue multiple, and (1.6x) EV/EBITDA.
Tern Financial Valuation Multiples
As of November 8, 2026, Tern has market cap of $11M and EV of $11M.
Tern has a P/E ratio of (1.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Tern Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Tern Margins & Growth Rates
In the most recent fiscal year, Tern reported EBITDA margin of (9503%) and net margin of (9424%).
Tern Margins
Tern Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Tern Operational KPIs
Tern's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.5M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Tern Competitors
Tern competitors include KDventures, Clal Biotechnology, Unfold.vc, Almeda Ventures, Netcapital, BTC Health, Bio Meat Foodtech, Scalare Partners Holdings, CodeLab Capital and MKB Nedsense.
Most Tern public comparables operate across PE & VC.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $170K | ($20M) | 35.2x | - | (0.3x) | - | |||
| - | ($6M) | - | - | (2.6x) | - | |||
| ($993K) | ($1M) | (8.8x) | - | (7.0x) | - | |||
| - | - | - | - | - | - | |||
| $869K | ($28M) | 13.6x | - | (0.4x) | - | |||
| $68K | ($414K) | 160.6x | - | (26.3x) | - | |||
| - | - | - | - | - | - | |||
| $10M | $3M | 3.2x | - | 10.2x | - | |||
This data is available for Pro users. Sign up to see all Tern competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Tern
Tern has acquired 2 companies to date.
Last acquisition by Tern was on May 26th 2016. Tern acquired Flexiant for undisclosed valuation.
Latest Acquisitions by Tern
| Description | Flexiant is a cloud orchestration software provider targeting service providers with its vendor-agnostic platform supporting multiple hypervisors. Flexiant Cloud Orchestrator includes metering, billing, and reseller features to accelerate service launches. | Cryptosoft is a data security platform for Internet of Things devices, protecting data at rest and in transit. San Francisco-headquartered with offices in Boston and Thames Valley, UK, it integrates with ThingWorx and AWS IoT. Deployments reduce attack surfaces in industrial sensors and smart grids. Partnerships cover semiconductor firms for embedded encryption. |
| HQ Country | ||
| HQ City | London | Bracknell |
| Deal Date | 26 May 2016 | 15 Sep 2014 |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Tern acquisitions and their M&A valuation multiples. Start Free Trial | ||
Investments by Tern
Tern has invested in 8 companies to date.
Latest investment by Tern was on July 28th 2026. Tern invested in Talking Medicines in their $157K Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by Tern
| Description | Talking Medicines is a social intelligence platform analyzing patient feedback for pharmaceutical companies using AI and natural language processing in PatientMetRx. Its Drug-GPT tool queries curated data from patients and healthcare professionals. The service targets the $30 billion pharmaceutical advertising sector to refine marketing strategies. | Talking Medicines is a social intelligence platform analyzing patient feedback for pharmaceutical companies using AI and natural language processing in PatientMetRx. Its Drug-GPT tool queries curated data from patients and healthcare professionals. The service targets the $30 billion pharmaceutical advertising sector to refine marketing strategies. | Device Authority is a UK-headquartered provider of IoT security platforms featuring automated device provisioning, key management, and policy enforcement. With a development center in San Ramon, California, it delivers KeyScaler software for scalable credential lifecycle management. The company addresses security in industrial, healthcare, and automotive sectors compliant with standards like NIST. Founded from a 2014 spin-out, Device Authority serves global enterprises with dynamic encryption solutions. | Talking Medicines is a social intelligence platform analyzing patient feedback for pharmaceutical companies using AI and natural language processing in PatientMetRx. Its Drug-GPT tool queries curated data from patients and healthcare professionals. The service targets the $30 billion pharmaceutical advertising sector to refine marketing strategies. | |
| HQ Country | |||||
| HQ City | Glasgow | Glasgow | Reading | Glasgow | |
| Deal Date | 28 Jul 2026 | 25 May 2026 | 22 May 2026 | 1 Feb 2024 | |
| Round | Seed | Undisclosed stage | Undisclosed stage | Seed | |
| Raised | $157K | $400K | $280K | $506K | |
| Investors | Tern | Tern | Tern | Tern | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Tern investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Tern
| When was Tern founded? | Tern was founded in 2004. |
| Where is Tern headquartered? | Tern is headquartered in United Kingdom. |
| How many employees does Tern have? | As of today, Tern has over 3 employees. |
| Is Tern publicly listed? | Yes, Tern is a public company listed on London Stock Exchange. |
| What is the stock symbol of Tern? | Tern trades under TERN ticker. |
| When did Tern go public? | Tern went public in 2006. |
| Who are competitors of Tern? | Tern main competitors include KDventures, Clal Biotechnology, Unfold.vc, Almeda Ventures, Netcapital, BTC Health, Bio Meat Foodtech, Scalare Partners Holdings, CodeLab Capital, MKB Nedsense. |
| What is the current market cap of Tern? | Tern's current market cap is $11M. |
| What is the current revenue of Tern? | Tern's last fiscal year revenue is $73K. |
| What is the current EV/Revenue multiple of Tern? | Current revenue multiple of Tern is 152.4x. |
| Is Tern profitable? | No, Tern is not profitable. |
| How many companies Tern has acquired to date? | As of November 2026, Tern has acquired 2 companies. |
| What was the largest acquisition by Tern? | None of the M&A deals Tern has completed have disclosed valuations. |
| What companies Tern acquired? | Tern acquired Cryptosoft and Flexiant. |
| In how many companies Tern has invested to date? | As of November 2026, Tern has invested in 8 companies. |
| What was the last Tern investment? | On 28th July 2026 Tern invested in Talking Medicines, participating in a $157K Seed round. |
| In what companies Tern invested in? | Tern invested in FundamentalVR, Seal Software, Device Authority, Konektio, Talking Medicines, Wyld Networks, Flexiant, and Cryptosoft. |
See public comps similar to Tern
Lists including Tern
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




